Primary record
Hexanamide, N-((1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl)-6-((7-nitro-2,1,3-benzoxadiazol-4-yl)amino)-
- 库存
- 3,603 克
- 纯度
- 98.3 %
- CAS
- 94885-02-6
化合物标识与属性
- CAS
- 94885-02-6
- PubChem CID
- 16219783
- SMILES
- CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO)NC(=O)CCCCCNC1=CC=C(C2=NON=C12)[N+](=O)[O-])O
- Canonical SMILES
- CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCNc1ccc([N+](=O)[O-])c2nonc12
名称与同义词
- C6 NBD Ceramide
- Nbd-ceramide
- C6-Nbd-ceramide
- C-6 NBD Ceramide
- C6-Nbd-cer
- NBD-C 6Cer
- C6-NBD Ceramide
- NBD C6-Ceramide
- NBD-C6-Cer
- 94885-02-6
- NBD hexanoic ceramide
- 39ZCU6EB2E
- RefChem:1091364
- CHEBI:59429
- Epitope ID:131179
- UNII-39ZCU6EB2E
- N-(NBD-Aminohexanoyl)sphingosine
- C30H49N5O6
- CHEMBL135464
- orb2278606
- SCHEMBL16216321
- N-(NBD-Aminohexanoyl) D-erythro-Sphingosine
- N-C6-NBD-D-erythro-Sphingosine
- DTXSID501334180
- C6 NBD Ceramide (d18:1/6:0)
- NBD Cer(18:1/2:0)
- MFCD00467024
- ZINC43380062
- C30-H49-N5-O6
- HY-W356116
- ?C6 NBD Ceramide (d18:1/6:0)
- N-(Nbd-aminohexanoyl)-D-erythro-sphingosine
- DA-51517
- CS-0467369
- FT-0629299
- NS00016772
- Hexanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-
- J1.229.291K
- J2.581.172K
- G77040
- N-{6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanoyl}sphingosine
- 86701-10-2
- N-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine
- Q27126704
- N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]-6-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]hexanamide
- 6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl)sphingosine
- N-[6-[(7-Nitrobenzofurazane-4-yl)amino]hexanoyl]sphingosine
- N-([7-Nitrobenz-2-oxa-1,3-diazol-4-yl]aminocaproyl)sphingosine
- N-(6-((7-Nitro-2-1,3-benzoxadiazol-4-yl)amino)hexanoyl)-D-erythro-sphingosine
- N-[(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)aminocaproyl]sphingosine
- (6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl)sphingosine)
- Hexanamide, N-((1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl)-6-((7-nitro-2,1,3-benzoxadiazol-4-yl)amino)-
- N-((1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl)-6-((7-nitro-2,1,3-benzoxadiazol-4-yl)amino)hexanamide
- N-(6-((7-nitro-2,1,3-benzoxadiazol-4-yl)amino)hexanoyl)sphingosine
- N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide
- N-[6-[(7-Nitro-2,1,3-benzooxadiazole-4-yl)amino]hexanoyl]sphingosine
- N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-erythro-sphingosine
- (2S,3R)-2-[6-[(7-Nitro-2,1,3-benzooxadiazole-4-yl)amino]hexanoylamino]-4-octadecene-1,3-diol
- Hexanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-
- N-((E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl)-6-((4-nitro-2,1,3-benzoxadiazol-7-yl)amino)hexanamide
- N-[(1S,2R,3E)-1-(Hydroxymethyl)-2-hydroxy-3-heptadecenyl]-6-(7-nitrobenzofurazane-4-ylamino)hexanamide
- N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide
- N-[(2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide
- N-[(2S,3R,4E)-1,3-Dihydroxy-4-octadecen-2-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide
- N-[(E,1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadec-3-enyl]-6-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]hexanamide